{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T07:41:30Z","timestamp":1768635690730,"version":"3.49.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2016,2,29]],"date-time":"2016-02-29T00:00:00Z","timestamp":1456704000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1007\/s10620-016-4091-8","type":"journal-article","created":{"date-parts":[[2016,2,29]],"date-time":"2016-02-29T06:08:04Z","timestamp":1456726084000},"page":"2373-2380","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":64,"title":["Helicobacter pylori Clarithromycin Resistance and Treatment Failure Are Common in the USA"],"prefix":"10.1007","volume":"61","author":[{"given":"Jason Y.","family":"Park","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kerry B.","family":"Dunbar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Midori","family":"Mitui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina A.","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dora M.","family":"Lam-Himlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark A.","family":"Valasek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Thung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chinemerem","family":"Okwara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Coss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byron","family":"Cryer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher D.","family":"Doern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,2,29]]},"reference":[{"key":"4091_CR1","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1056\/NEJMoa001999","volume":"345","author":"N Uemura","year":"2001","unstructured":"Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 2001;345:784\u2013789.","journal-title":"N Engl J Med"},{"key":"4091_CR2","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0140-6736(08)61159-9","volume":"372","author":"K Fukase","year":"2008","unstructured":"Fukase K, Kato M, Kikuchi S, et al. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet. 2008;372:392\u2013397.","journal-title":"Lancet"},{"key":"4091_CR3","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/S0140-6736(88)90929-4","volume":"2","author":"BJ Marshall","year":"1988","unstructured":"Marshall BJ, Goodwin CS, Warren JR, et al. Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet. 1988;2:1437\u20131442.","journal-title":"Lancet"},{"key":"4091_CR4","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S1473-3099(06)70627-2","volume":"6","author":"MM Gerrits","year":"2006","unstructured":"Gerrits MM, van Vliet AH, Kuipers EJ, Kusters JG. Helicobacter pylori and antimicrobial resistance: molecular mechanisms and clinical implications. Lancet Infect Dis. 2006;6:699\u2013709.","journal-title":"Lancet Infect Dis"},{"key":"4091_CR5","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/MPG.0b013e3182227e90","volume":"53","author":"S Koletzko","year":"2011","unstructured":"Koletzko S, Jones NL, Goodman KJ, et al. Evidence-based guidelines from ESPGHAN and NASPGHAN for Helicobacter pylori infection in children. J Pediatr Gastroenterol Nutr. 2011;53:230\u2013243.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"4091_CR6","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1136\/gutjnl-2012-302084","volume":"61","author":"P Malfertheiner","year":"2012","unstructured":"Malfertheiner P, Megraud F, O\u2019Morain CA, et al. Management of Helicobacter pylori infection\u2014the Maastricht IV\/Florence consensus report. Gut. 2012;61:646\u2013664.","journal-title":"Gut"},{"key":"4091_CR7","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/MPG.0000000000000380","volume":"59","author":"M Mitui","year":"2014","unstructured":"Mitui M, Patel A, Leos NK, Doern CD, Park JY. Novel Helicobacter pylori sequencing test identifies high rate of clarithromycin resistance. J Pediatr Gastroenterol Nutr. 2014;59:6\u20139.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"4091_CR8","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1128\/AAC.42.8.1952","volume":"42","author":"G Wang","year":"1998","unstructured":"Wang G, Taylor DE. Site-specific mutations in the 23S rRNA gene of Helicobacter pylori confer two types of resistance to macrolide-lincosamide-streptogramin B antibiotics. Antimicrob Agents Chemother. 1998;42:1952\u20131958.","journal-title":"Antimicrob Agents Chemother"},{"key":"4091_CR9","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1111\/j.1572-0241.2007.01393.x","volume":"102","author":"WD Chey","year":"2007","unstructured":"Chey WD, Wong BC. American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Am J Gastroenterol. 2007;102:1808\u20131825.","journal-title":"Am J Gastroenterol"},{"key":"4091_CR10","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1038\/modpathol.2013.48","volume":"26","author":"BH Schmitt","year":"2013","unstructured":"Schmitt BH, Regner M, Mangold KA, Thomson RB Jr, Kaul KL. PCR detection of clarithromycin-susceptible and -resistant Helicobacter pylori from formalin-fixed, paraffin-embedded gastric biopsies. Mod Pathol. 2013;26:1222\u20131227.","journal-title":"Mod Pathol"},{"key":"4091_CR11","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1016\/j.cgh.2015.02.005","volume":"13","author":"S Shiota","year":"2015","unstructured":"Shiota S, Reddy R, Alsarraj A, El-Serag HB, Graham DY. Antibiotic Resistance of Helicobacter pylori Among Male United States Veterans. Clin Gastroenterol Hepatol. 2015;13:1616\u20131624.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"4091_CR12","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/j.1523-5378.2006.00462.x","volume":"11","author":"MG Bruce","year":"2006","unstructured":"Bruce MG, Bruden DL, McMahon BJ, et al. Alaska sentinel surveillance for antimicrobial resistance in Helicobacter pylori isolates from Alaska native persons, 1999\u20132003. Helicobacter. 2006;11:581\u2013588.","journal-title":"Helicobacter"},{"key":"4091_CR13","doi-asserted-by":"crossref","first-page":"3638","DOI":"10.1128\/JCM.01067-11","volume":"49","author":"AH Tveit","year":"2011","unstructured":"Tveit AH, Bruce MG, Bruden DL, et al. Alaska sentinel surveillance study of Helicobacter pylori isolates from Alaska Native persons from 2000 to 2008. J Clin Microbiol. 2011;49:3638\u20133643.","journal-title":"J Clin Microbiol"},{"key":"4091_CR14","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1053\/j.gastro.2012.05.012","volume":"143","author":"DY Graham","year":"2012","unstructured":"Graham DY, Shiotani A. Which therapy for Helicobacter pylori infection? Gastroenterology. 2012;143:10\u201312.","journal-title":"Gastroenterology"},{"key":"4091_CR15","doi-asserted-by":"crossref","first-page":"13","DOI":"10.7326\/0003-4819-136-1-200201010-00008","volume":"136","author":"JM Meyer","year":"2002","unstructured":"Meyer JM, Silliman NP, Wang W, et al. Risk factors for Helicobacter pylori resistance in the United States: the surveillance of H. pylori antimicrobial resistance partnership (SHARP) study, 1993\u20131999. Ann Intern Med. 2002;136:13\u201324.","journal-title":"Ann Intern Med"},{"key":"4091_CR16","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1001\/archinte.161.9.1217","volume":"161","author":"MS Osato","year":"2001","unstructured":"Osato MS, Reddy R, Reddy SG, Penland RL, Malaty HM, Graham DY. Pattern of primary resistance of Helicobacter pylori to metronidazole or clarithromycin in the United States. Arch Intern Med. 2001;161:1217\u20131220.","journal-title":"Arch Intern Med"},{"key":"4091_CR17","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.3201\/eid1006.030744","volume":"10","author":"WM Duck","year":"2004","unstructured":"Duck WM, Sobel J, Pruckler JM, et al. Antimicrobial resistance incidence and risk factors among Helicobacter pylori-infected persons, United States. Emerg Infect Dis. 2004;10:1088\u20131094.","journal-title":"Emerg Infect Dis"},{"key":"4091_CR18","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1007\/s100960100611","volume":"20","author":"Y Glupczynski","year":"2001","unstructured":"Glupczynski Y, Megraud F, Lopez-Brea M, Andersen LP. European multicentre survey of in vitro antimicrobial resistance in Helicobacter pylori. Eur J Clin Microbiol Infect Dis. 2001;20:820\u2013823.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"4091_CR19","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1136\/gutjnl-2012-302254","volume":"62","author":"F Megraud","year":"2013","unstructured":"Megraud F, Coenen S, Versporten A, et al. Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption. Gut. 2013;62:34\u201342.","journal-title":"Gut"},{"key":"4091_CR20","doi-asserted-by":"crossref","first-page":"3600","DOI":"10.1128\/JCM.00744-09","volume":"47","author":"E Cambau","year":"2009","unstructured":"Cambau E, Allerheiligen V, Coulon C, et al. Evaluation of a new test, genotype HelicoDR, for molecular detection of antibiotic resistance in Helicobacter pylori. J Clin Microbiol. 2009;47:3600\u20133607.","journal-title":"J Clin Microbiol"},{"key":"4091_CR21","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/modpathol.3800098","volume":"17","author":"S Juttner","year":"2004","unstructured":"Juttner S, Vieth M, Miehlke S, et al. Reliable detection of macrolide-resistant Helicobacter pylori via fluorescence in situ hybridization in formalin-fixed tissue. Mod Pathol. 2004;17:684\u2013689.","journal-title":"Mod Pathol"},{"key":"4091_CR22","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1128\/JCM.00103-07","volume":"45","author":"C Lottspeich","year":"2007","unstructured":"Lottspeich C, Schwarzer A, Panthel K, Koletzko S, Russmann H. Evaluation of the novel Helicobacter pylori ClariRes real-time PCR assay for detection and clarithromycin susceptibility testing of H. pylori in stool specimens from symptomatic children. J Clin Microbiol. 2007;45:1718\u20131722.","journal-title":"J Clin Microbiol"},{"key":"4091_CR23","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1469-0691.2012.03844.x","volume":"19","author":"A Cosme","year":"2013","unstructured":"Cosme A, Montes M, Martos M, et al. Usefulness of antimicrobial susceptibility in the eradication of Helicobacter pylori. Clin Microbiol Infect. 2013;19:379\u2013383.","journal-title":"Clin Microbiol Infect"},{"key":"4091_CR24","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/ncpgasthep1138","volume":"5","author":"DY Graham","year":"2008","unstructured":"Graham DY, Shiotani A. New concepts of resistance in the treatment of Helicobacter pylori infections. Nat Clin Pract Gastroenterol Hepatol. 2008;5:321\u2013331.","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"4091_CR25","unstructured":"http:\/\/seer.cancer.gov\/statfacts\/html\/stomach.html . Last Accessed January 19, 2016."},{"key":"4091_CR26","first-page":"CD005583","volume":"7","author":"AC Ford","year":"2015","unstructured":"Ford AC, Forman D, Hunt R, Yuan Y, Moayyedi P. Helicobacter pylori eradication for the prevention of gastric neoplasia. Cochrane Database Syst Rev. 2015;7:CD005583.","journal-title":"Cochrane Database Syst Rev"},{"key":"4091_CR27","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.semcancer.2013.07.004","volume":"23","author":"A Shiotani","year":"2013","unstructured":"Shiotani A, Cen P, Graham DY. Eradication of gastric cancer is now both possible and practical. Semin Cancer Biol. 2013;23:492\u2013501.","journal-title":"Semin Cancer Biol"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-016-4091-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-016-4091-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-016-4091-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,5]],"date-time":"2022-06-05T17:27:23Z","timestamp":1654450043000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-016-4091-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,29]]},"references-count":27,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["4091"],"URL":"https:\/\/doi.org\/10.1007\/s10620-016-4091-8","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,29]]}}}